Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AXL modulators(AXL receptor tyrosine kinase modulators), BRD4 modulators(Bromodomain-containing protein 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Model Medicines, Inc.Startup |
Active Organization Model Medicines, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thyroid Cancer | Preclinical | US | Model Medicines, Inc.Startup | 28 Jun 2024 |